The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Minimal Change Disease- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Minimal Change Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pip...
February 2021
60 pages
Molluscum Contagiosum - Pipeline Insight
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Molluscum Contagiosum - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pi...
February 2021
60 pages
Mucinous cystic neoplasm - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucinous cystic neoplasm - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
February 2021
60 pages
Nasal Polyposis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Nasal Polyposis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline d...
February 2021
60 pages
Natural Killer T Cell Lymphoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Natural Killer T Cell Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies an...
February 2021
60 pages
Necrobiosis Lipoidica - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrobiosis Lipoidica - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...
February 2021
60 pages
Necrotizing Enterocolitis – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrotizing Enterocolitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...
February 2021
60 pages
Netherton Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Netherton Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipelin...
February 2021
60 pages
Niemann Pick C Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Niemann Pick C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...
February 2021
60 pages
Opioid Withdrawal Syndrome-Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Opioid withdrawal syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...
February 2021
60 pages
Palmoplantar Keratoderma- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Keratoderma – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ p...
February 2021
60 pages
Palmoplantar Pustulosis- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Pustulosis – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pi...
February 2021
60 pages
Pericarditis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pericarditis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drug...
February 2021
60 pages
Pneumococcal Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pneumococcal Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipel...
February 2021
60 pages
Polypoidal choroidal vasculopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Polypoidal choroidal vasculopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...
February 2021
60 pages
Pre-Eclampsia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pre-Eclampsia – Pipeline Insight, 2021,” report provides comprehensive insights about companies and pipeline drugs in...
February 2021
60 pages
Pseudomonas aeruginosa infection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pseudomonas aeruginosa infection - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies...
February 2021
60 pages
Rabies virus - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Rabies virus - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline dr...
February 2021
60 pages
Radiodermatitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Radiodermatitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
February 2021
60 pages
Refractory Metastatic Melanoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies a...
February 2021
60 pages
Refractory Multiple Myeloma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Refractory Multiple Myeloma – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...
February 2021
60 pages
Refractory Status Epilepticus - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Refractory Status Epilepticus - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
February 2021
60 pages
Sebohrrea- Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Seborrhea – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs i...
February 2021
60 pages
Seborrhoeic Dermatitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Seborrhoeic Dermatitis - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pip...
February 2021
60 pages
Shigellosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Shigellosis - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs...
February 2021
60 pages
Small Fiber Neuropathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Small Fiber Neuropathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pip...
February 2021
60 pages
Vascular Calcification - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Vascular Calcification – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pip...
February 2021
60 pages
X-linked retinitis pigmentosa – Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “X-linked retinitis pigmentosa – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and...
February 2021
60 pages
ABEXINOSTAT- Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ABEXINOSTAT- Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
ACI-24 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ACI-24 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Dow...
February 2021
30 pages
AD036 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “AD036 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Obst...
February 2021
30 pages
AD128 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “AD128 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Obst...
February 2021
30 pages
ASN002 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ASN002 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Chr...
February 2021
30 pages
BETALUTIN - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BETALUTIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
BIIB059 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “BIIB059 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cu...
February 2021
30 pages
Copiktra - Drug Insight and Market Forecast - 2030
US$ 2,750.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Copiktra - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicat...
February 2021
30 pages
CSL312 - Emerging Insight and Market Forecast- 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “CSL312 - Emerging Insight and Market Forecast- 2030” the report provides comprehensive insights about an investigational product for Here...
February 2021
30 pages
DARIDOREXANT - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “Daridorexant - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
Delgocitinib - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “Delgocitinib - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
